Clinical Secretary - Neurology Dartmouth-Hitchcock HealthClinical Secretary - NeurologyNashua, New HampshireGreets patients arriving for appointments, provides appropriate questionnaire(s), answer questions and assists patients with completion of forms and use of technology, acknowledges any delays and keeps patient updated. Reviews wait list, manages multiple e-DH worklists and reschedules patients to assure schedules are fully booked and patients’ needs are met.
Clinical Secretary - Orthopaedics Dartmouth-Hitchcock HealthClinical Secretary - OrthopaedicsNashua, New HampshireGreets patients arriving for appointments, provides appropriate questionnaire(s), answer questions and assists patients with completion of forms and use of technology, acknowledges any delays and keeps patient updated. Reviews wait list, manages multiple e-DH worklists and reschedules patients to assure schedules are fully booked and patients’ needs are met.
Executive Director/Vice President, Clinical Development Seaport TherapeuticsExecutive Director/Vice President, Clinical DevelopmentBoston, MassachusettsManage effective internal and external relationships, internally with members of the executive leadership team, regulatory affairs, clinical operations and medical affairs, and externally including regulatory agencies, partners, KOLs, and investigators. This role will report to the Chief Medical Officer and oversee clinical trial design and execution, partner with regulatory strategy, biostatistics, program management and other cross-functional stakeholders and external partners including regulatory agencies, KOLs, and investigators.
Director Of Clinical Pharmacology, Cambridge, MA Isomorphic LabsDirector Of Clinical Pharmacology, Cambridge, MACambridge, MACRO Management: Oversee and partner with global clinical CROs to ensure the high-quality, timely, and cost-effective execution of clinical pharmacology studies and human bioanalysis and PK data analyses within broader oncology and non-oncology clinical trials. Data Analysis: Direct the analysis, interpretation, and reporting of bioanalytical PK data from clinical trials and human AME (mass balance) studies; utilize appropriate modeling approaches (e.g., PopPK, exposure-response) to inform dose optimization and the recommended phase 2 dose/schedule (RP2D) selection for pivotal studies.